XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 4,816,561 $ 6,995,525
Research and development tax credit receivable 1,044,843 568,139
Other tax receivable 155,000 77,225
Prepaid expenses 342,492 97,623
Prepaid expenses - related party 26,266
TOTAL CURRENT ASSETS 6,358,896 7,764,778
Operating lease - right of use asset - related party 174,649 191,543
Acquired in-process research and development intangible assets 16,514,000 16,514,000
TOTAL ASSETS 23,047,545 24,470,321
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 624,893 401,989
Accounts payable and accrued liabilities - related parties 223,562 290,102
Deferred liabilities 361,842
Operating lease, current liability - related party 6,950 8,288
TOTAL CURRENT LIABILITIES 1,217,247 700,379
Long-term operating lease liability - related party 145,430 160,164
TOTAL LIABILITIES 1,362,677 860,543
COMMITMENTS AND CONTINGENCIES  
STOCKHOLDERS' EQUITY    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.001 par value, 200,000,000 shares authorized, 10,897,630 and 10,770,948 shares issued and outstanding, respectively 10,898 10,771
Additional paid-in capital 47,068,236 44,833,703
Common stock issuable 50,000 50,000
Accumulated other comprehensive loss 10,126 (8,515)
Accumulated deficit (25,454,392) (21,276,181)
TOTAL STOCKHOLDERS' EQUITY 21,684,868 23,609,778
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 23,047,545 $ 24,470,321